Drug Database · Clinicians

Chlorphenamine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine

Also known as: chlorpheniramine (US name, for chlorphenamine) · guaiphenesin (former British name, for guaifenesin) · acetaminophen (US name, for paracetamol)

Brands (9) Ac-Nex Forte, Cinquesaph, Codexin-DM…Show all

Analgesic/ antipyretic/ expectorant/ nasal decongestant/ antitussive/ antihistamine; Analgesic/Antipyretic/Expectorant/Decongestant/Antitussive/Antihistamine; and others PH FDA category
Fixed-dose combination.

Controlled precursorRx · Prescription drugOTC · Over-the-counter9 PH products

1988 Convention Table I (norephedrine); FDA-registered oral preparations are exempt from all DDB regulatory requirements except registration and licensing of the importer, exporter and manufacturer; prescription and dispensing follow FDA rules (BR 1 s.2014 Sec. 4(5)). Parenteral preparations are not covered by this exemption (Sec. 4(2)(c)(i)); prescribing a drug preparation containing a controlled chemical otherwise requires a PDEA S-2 license (Sec. 6(3)).; BR 1 s.2014 Sec. 6(14)-(15): preparations with norephedrine/phenylpropanolamine 25 mg or below that are classified over-the-counter may be advertised to the public and distributed as samples; the S-2 license fee schedule (Sec. 6) likewise excludes them. The precursor exemption for oral FDA-registered preparations applies to combinations as well (BR 1 s.2014 Sec. 4(5)). Source: DDB, Updated Lists of Scheduled Controlled Substances (as of 20 July 2026); DDB Board Regulation No. 1, s. 2014 (amending BR 3 s. 2003: licensing, prescriptions, exemptions).

Dispensing: Over-the-counter (OTC) · Prescription (Rx) · Controlled precursor Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat US FDA label

  • Use: Uses temporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritants the impulse to cough to help you get to sleep US FDA label

  • Use: Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive US FDA label

  • Use: Uses temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Capsule: 15 mg/50 mg/1 mg/325 mg/30 mg, 250 mg/100 mg/25 mg/10 mg/1 mg, 325 mg/50 mg/10 mg/10 mg/2 mg, 325 mg/50 mg/12.5 mg/10 mg/1 mg, 325 mg/50 mg/30 mg/15 mg/1 mg

Registered products in the Philippines

9 products registered with the Food and Drug Administration (FDA) Philippines list Chlorphenamine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Paracetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorpheniramine Maleate (3 products). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products9
Philippine FDA-registered products for Chlorphenamine + Dextromethorphan + Guaifenesin + Paracetamol + Phenylpropanolamine
Package insert
Ac-Nex ForteParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorpheniramine MaleateVariant spelling
250 mg/100 mg/25 mg/10 mg/1 mg CapsuleAlu/PE Foil Strip x 10's (Box of 100's); Alu/PE Foil Strip x 1's as Physician's Sample
Rx
La Croesus Pharma, Inc.Philippines
Trader: Medical and Pharmaceutical Specialties, Inc.
DR-XY42713
Sep 30, 2028
CinquesaphParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorphenamine Maleate
325 mg/50 mg/12.5 mg/10 mg/1 mg CapsuleAlu/PVC Dark Maroon Colored Blister Pack x 10's (Box of 100's)
OTC
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-11086
May 26, 2031
Codexin-DMParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorpheniramine MaleateVariant spelling
250 mg/100 mg/25 mg/10 mg/1 mg CapsuleAlu/PE Foil Strip x 10's (Box of 100's)
OTC
La Croesus Phara, Inc.Philippines
Trader: Medical and Pharmaceutical Specialties, Inc.
DRP-17496
Jan 14, 2031
CoughlogenParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorphenamine Maleate
325 mg/50 mg/12.5 mg/10 mg/1 mg CapsuleAlu-Strip Foil Pack x 10's (Box of 100's)
OTC
Azarias Pharmaceutical Laboratories, Inc.Philippines
Trader: Eba Generisch Trading, Inc.
DRP-9268
Mar 9, 2031
DexofenParacetamol + Guaifenesin + Phenylpropanolamine (as hydrochloride) + Dextromethorphan hydrobromide + Chlorpheniramine maleateVariant spelling
325 mg/50 mg/10 mg/10 mg/2 mg CapsuleAlu/Alu Stripped Foil x 10's (Box of 100's)
OTC
Drugmaker's Laboratories, Inc.Philippines
Trader: CHMI Pharma, Inc.
DR-XY48824
Jul 31, 2028
DexorinParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorphenamine Maleate
325 mg/50 mg/30 mg/15 mg/1 mg CapsuleAlu/Alu Blister Pack x 10’s (Box of 100’s)
OTC
Huazhong Pharmaceuticals Co., Ltd.China
AMB HK Enterprises Inc.
DRP-18794
Sep 8, 2031
DynatussinDextromethorphan hydrobromide/ Guaifenesin/ Chlorphenamine maleate/ Paracetamol/ Phenylpropanolamine hydrochloride
15 mg/ 50 mg/ 1 mg/ 325 mg/ 30 mg CapsuleFoil Strip x 10's Box of 100's
Rx
Swisspharma Research Laboratories, Inc.Philippines
Trader: Crisdy-Na Drug Corporation
DR-XY18308
Oct 29, 2027
Mucotuss ForteParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorphenamine Maleate
325 mg/ 50 mg/ 12.5 mg/ 10 mg/ 1 mg CapsuleAluminum Foil Strip x 10's (Box of 100's)
Rx
Drugmaker's Laboratories, Inc.Philippines
Trader: Terramedic, Inc.
DRP-8224
Oct 13, 2030
RaphctussParacetamol + Guaifenesin + Phenylpropanolamine Hydrochloride + Dextromethorphan Hydrobromide + Chlorphenamine Maleate
325 mg/50 mg/12.5 mg/10 mg/1 mg CapsuleAlu Strip Foil Pack x 10's (Box of 100's)
Rx
Azarias Pharmaceutical Laboratories Inc.Philippines
Trader: St. Raphael Archangel Pharmaceutical Product Distribution
DRP-9559
Feb 24, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .